- Joined
- Jan 4, 2021
Not sure about Pfizer, but I remembered reading that Moderna went from a loss to over a billion in earnings. This is the first time that they have generated PRODUCT revenue. Previously, their revenue came from grant/collaboration.BWA HA HA HA HA!!!!!
Oh that's... that's funny.
You're kidding yourself if you don't think Pfizer isn't making BILLIONS off of government contracts.
Moderna reports $1.7 billion in COVID-19 vaccine sales, posts first profit ever
Archive
Moderna Inc. MRNA, 0.64% brought in $1.7 billion in sales of its COVID-19 vaccine in the first quarter of 2021, marking the company's first significant billion-dollar revenue haul this year and also the first time it's ever reported a GAAP profit. Moderna had earnings of $1.2 billion, or $2.84 per share, in the first quarter of 2021. This is compared to a loss of $124 million, or 35 cents per share, in the first quarter a year ago. The FactSet consensus was $2.39. Moderna had revenue of $1.9 billion for the quarter, up from $8 million in the same quarter a year ago. The FactSet consensus for revenue was $2.0 billion. This quarter marked the first time that the company has generated product revenue during the first three months of the year. About $1.7 billion of that came from sales of its COVID-19 vaccine. (Before receiving authorization from the Food and Drug Administration, it generated grant and collaboration revenue.) Moderna's stock is up 55.8% for the year, while the S&P 500 SPX, -0.11% has gained 10.9%